A clinical phase I dose-finding design with adaptive shrinking boundaries for drug combination trials

被引：0
|
作者：
Zhaohang Li
Ze Xu
Aijun Zhang
Guanpeng Qi
Zuojing Li
机构：
[1] Shenyang Pharmaceutical University,Department of Pharmaceutical Informatics, Academy of Pharmacy
来源：
BMC Medical Research Methodology | / 23卷
关键词：
Dose escalation; Model-assisted design; Drug combination; Bayesian adaptive dose-finding design; Phase I clinical trial design;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] A dose-finding approach for genomic patterns in phase I trials
    Kaneko, S.
    Hirakawa, A.
    Kakurai, Y.
    Hamada, C.
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2020, 30 (05) : 834 - 853
  • [32] Dose-finding with two agents in phase I oncology trials
    Thall, PF
    Millikan, RE
    Mueller, P
    Lee, SJ
    [J]. BIOMETRICS, 2003, 59 (03) : 487 - 496
  • [33] An integrated dose-finding tool for phase I trials in oncology
    Yang, Shengjie
    Wang, Sue-Jane
    Ji, Yuan
    [J]. CONTEMPORARY CLINICAL TRIALS, 2015, 45 : 426 - 434
  • [34] Flexible use of copula-type model for dose-finding in drug combination clinical trials
    Hashizume, Koichi
    Tshuchida, Jun
    Sozu, Takashi
    [J]. BIOMETRICS, 2022, 78 (04) : 1651 - 1661
  • [35] Toxicity and efficacy probability intervals design for phase I dose-finding in oncology trials
    Li, Daniel H.
    Whitmore, Jim
    Ji, Yuan
    [J]. CANCER RESEARCH, 2016, 76
  • [36] Target toxicity design for phase I dose-finding
    Guo, Wenchuan
    Zhong, Bob
    [J]. STATISTICAL THEORY AND RELATED FIELDS, 2021, 5 (02) : 149 - 161
  • [37] A comparison of phase I dose-finding designs in clinical trials with monotonicity assumption violation
    Abbas, Rachid
    Rossoni, Caroline
    Jaki, Thomas
    Paoletti, Xavier
    Mozgunov, Pavel
    [J]. CLINICAL TRIALS, 2020, 17 (05) : 522 - 534
  • [38] Dose-finding methods for Phase I clinical trials using pharmacokinetics in small populations
    Ursino, Moreno
    Zohar, Sarah
    Lentz, Frederike
    Alberti, Corinne
    Friede, Tim
    Stallard, Nigel
    Comets, Emmanuelle
    [J]. BIOMETRICAL JOURNAL, 2017, 59 (04) : 804 - 825
  • [39] Uniformly most powerful Bayesian interval design for phase I dose-finding trials
    Lin, Ruitao
    Yin, Guosheng
    [J]. PHARMACEUTICAL STATISTICS, 2018, 17 (06) : 710 - 724
  • [40] Bayesian optimization design for dose-finding based on toxicity and efficacy outcomes in phase I/II clinical trials
    Takahashi, Ami
    Suzuki, Taiji
    [J]. PHARMACEUTICAL STATISTICS, 2021, 20 (03) : 422 - 439
12345